Insider filing · MDGL
Fred B Craves
Director
profile →
Madrigal Pharmaceuticals, Inc.
MDGL · Healthcare · 60 filings in 24 months
ticker →
Fred B Craves sold $5.0M of Madrigal Pharmaceuticals (MDGL)
Executed Mar 12 2025, disclosed Mar 14 2025, 2 days later.
Value, as filed
$5.0M
15,195 sh across 11 lots
Executed
Mar 12 2025
the trade date, as filed
Disclosed
Mar 14 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
FCFred B Craves (Director) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $5.0M of MDGL (15,195 sh across 11 lots, as filed), executed Mar 12 2025.
The name
MDGLHealthcare · Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Fred B Craves in MDGL
MDGLSALE
Madrigal Pharmaceuticals, Inc.
$1.1M3,600 sh across 2 lots
Exec Dec 3 2024
Filed Dec 5 2024 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $1.2M
3,400 sh across 2 lots
Exec Nov 25 2024
Filed Nov 27 2024 · 5:30 PM ET